Similar articles

• [Determination of anti-Scl-70 antibody and its clinical significance in progressive systemic sclerosis].

  Jiang M. Jiang M. Zhonghua Yi Xue Za Zhi. 1986 Jun;66(6):346-8, 384. Zhonghua Yi Xue Za Zhi. 1986. PMID: 3094898 Chinese. No abstract available.
• [Antinuclear antibody profile in progressive systemic sclerosis. A multicenter study].

  Martínez-Cordero E, Burgos-Vargas R, Herrera-Esparza R, Reyes PA. Martínez-Cordero E, et al. Rev Invest Clin. 1983 Oct-Dec;35(4):273-7. Rev Invest Clin. 1983. PMID: 6369466 Spanish. No abstract available.
• [Determination of antinuclear autoantibodies in progressive systemic sclerosis and its clinical significance].

  Jiang M, Wang HZ, Yuan X. Jiang M, et al. Zhonghua Nei Ke Za Zhi. 1988 Feb;27(2):112-4, 136. Zhonghua Nei Ke Za Zhi. 1988. PMID: 3053068 Chinese. No abstract available.
• [Occurrence of autoantibodies and the clinical course of mixed connective tissue disease, systemic scleroderma, dermatomyositis, polymyositis and Sjögren's syndrome].

  Prokop J, Zietkiewicz E, Słomski R. Prokop J, et al. Przegl Dermatol. 1986 Jul-Aug;73(4):327-31. Przegl Dermatol. 1986. PMID: 3333867 Review. Polish. No abstract available.
• [Systemic scleroderma].

  Sollberg S, Krieg T. Sollberg S, et al. Hautarzt. 1995 Aug;46(8):587-601; quiz 600-1. doi: 10.1007/s001050050304. Hautarzt. 1995. PMID: 7558832 Review. German. No abstract available.